NEW YORK, March 2 (GenomeWeb News) - Biolog yesterday said that it has received a new patent for its Phenotype Microarray technology - the 21st patent for the company's cellular assay technology platform.
The patent, number US 6,686,173, entitled, "Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device," protects a method for comparing the phenotypes of two or more microorganisms within a microwell device.
The patent covers the phenotypic analysis of eukaryotic as well as prokaryotic cells. The company said that its Phenotype Microarray technology has already been applied to a number of bacteria and fungi, including Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus spp., Bacillus spp., Saccharomyces cerevisiae, Candida albicans, and Aspergillus spp.
In June, Biolog received an SBIR grant from the National Cancer Institute to extend the platform to human and mouse cell lines.